Results 1 - 1 of 1 for DINUTUXIMAB
  1. ... trial, the FDA approved the antibody therapy drug dinutuximab for high-risk neuroblastoma. The drug binds to ... the trial who received two transplants, followed by dinutuximab, lived substantially longer without their cancer progressing. Childhood ...